New U.S. COVID-19 vaccinations climb for the longest stretch in months
Nov 05, 2021
At least some of the recent surge in first doses also could be from incorrectly reported booster shots, however.
Results mixed for use of zinc for acute viral RTIs in adults
Nov 02, 2021
Some evidence suggests that zinc might shorten the duration of symptoms, but further research is needed to address many unanswered questions.
Risk for progression to severe COVID-19 lower with nirmatrelvir + ritonavir
Mar 01, 2022
Treatment of symptomatic COVID-19 with nirmatrelvir plus ritonavir was linked to an 89% lower risk for progression versus placebo.
USPSTF updates guidance on statins for primary prevention of cardiovascular disease
Feb 22, 2022
The evidence currently is insufficient for assessing the balance of benefits and harms of statin initiation for primary prevention of CVD and mortality in adults aged 76 years or older.
Remdesivir offers some benefit for hospitalized COVID-19 patients
Feb 01, 2022
No difference was seen for in-hospital mortality, but a need for initiation of mechanical ventilation was reduced with the addition of remdesivir to standard care.
Half of American workers support COVID-19 vaccination, mask mandates in workplace
Aug 27, 2021
The poll was conducted before the FDA granted full approval to the Pfizer COVID-19 vaccine.
Awake prone positioning no benefit for COVID-19-linked hypoxemia
Apr 20, 2022
Evidence shows worse clinical outcomes on day 5 for the intervention group versus the usual-care group.
COVID-19 vaccine concerns ID’d in psoriasis, psoriatic arthritis patients
Oct 07, 2021
Patient hesitancy stems from concerns about the safety of the vaccine and whether the vaccine would aggravate their underlying condition.
Oral inosine does not slow progression of early Parkinson’s disease
Sep 16, 2021
No significant difference was seen in the rate of clinical disease progression or in secondary efficacy outcomes versus placebo.
High demand for at-home COVID-19 tests could hamper supply, Abbott Says
Aug 30, 2021
Sales have skyrocketed due to the surge in cases driven by the highly transmissible delta variant.